We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$15.1B
AUM Growth
+$742M
Cap. Flow
-$196M
Cap. Flow %
-1.3%
Top 10 Hldgs %
36.33%
Holding
1,380
New
61
Increased
578
Reduced
366
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 54.29%
2 Technology 12.23%
3 Consumer Discretionary 4.83%
4 Communication Services 4.52%
5 Healthcare 4.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
1201
Cogent Biosciences
COGT
$6.91B
$3K ﹤0.01%
281
COLL icon
1202
Collegium Pharmaceutical
COLL
$1.15B
$3K ﹤0.01%
127
HDV
1203
iShares Core High Dividend ETF
HDV
$14.5B
0
INVA icon
1204
Innoviva
INVA
$1.57B
$3K ﹤0.01%
260
LYEL icon
1205
Lyell Immunopharma
LYEL
$318M
$3K ﹤0.01%
46
RGNX icon
1206
Regenxbio
RGNX
$622M
$3K ﹤0.01%
146
ALEC icon
1207
Alector
ALEC
$168M
$2K ﹤0.01%
277
AMRN
1208
Amarin Corp
AMRN
$290M
$2K ﹤0.01%
67
ANAB icon
1209
AnaptysBio
ANAB
$1.59B
$2K ﹤0.01%
105
ARQT icon
1210
Arcutis Biotherapeutics
ARQT
$3.48B
$2K ﹤0.01%
245
BMEA icon
1211
Biomea Fusion
BMEA
$91.1M
$2K ﹤0.01%
109
DYN icon
1212
Dyne Therapeutics
DYN
$4.24B
$2K ﹤0.01%
210
EWTX icon
1213
Edgewise Therapeutics
EWTX
$4.48B
$2K ﹤0.01%
254
FATE icon
1214
Fate Therapeutics
FATE
$283M
$2K ﹤0.01%
360
LKFT
1215
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$2K ﹤0.01%
51
HCM icon
1216
HUTCHMED
HCM
$1.91B
$2K ﹤0.01%
185
HLVX
1217
DELISTED
HilleVax
HLVX
$2K ﹤0.01%
134
HROW icon
1218
Harrow
HROW
$1.4B
$2K ﹤0.01%
110
ITOS
1219
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
121
KNSA icon
1220
Kiniksa Pharmaceuticals
KNSA
$4.89B
$2K ﹤0.01%
139
KURA icon
1221
Kura Oncology
KURA
$901M
$2K ﹤0.01%
227
MCRB icon
1222
Seres Therapeutics
MCRB
$47M
$2K ﹤0.01%
25
NRIX icon
1223
Nurix Therapeutics
NRIX
$2.43B
$2K ﹤0.01%
152
NVAX icon
1224
Novavax
NVAX
$1.23B
$2K ﹤0.01%
291
PHAT icon
1225
Phathom Pharmaceuticals
PHAT
$953M
$2K ﹤0.01%
167

Similar funds

Daiwa Securities Group's Q2 2023 Portfolio in Review

As of Q2 2023, Daiwa Securities Group held 1,380 positions worth $15.1B, up 5.2% from $14.4B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q2 2023 filing shows 61 new, 578 increased, 366 reduced and 37 closed positions. Its largest new stake was Applovin: 95,413 shares worth $2.46M. The largest sale was Public Storage, an estimated $213M.

By sector, the portfolio is most concentrated in Real Estate at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q2 2023 buy was Applovin: 95,413 shares worth $2.46M.
  • Daiwa Securities Group added most to Simon Property Group in Q2 2023, an estimated $105M increase.
  • Daiwa Securities Group's biggest Q2 2023 reduction was Public Storage, cutting an estimated $213M.
  • Daiwa Securities Group fully exited BWX Technologies in Q2 2023, selling an estimated $6.7M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $15.1B portfolio in Q2 2023.
  • Daiwa Securities Group opened 61 new positions and closed 37 in Q2 2023.
  • Daiwa Securities Group's portfolio value rose 5.2% quarter-over-quarter to $15.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2023, filed 31 Jul 2023.